Company News
Ajanta Pharma FY26 Sustainability Report Submission
Ajanta Pharma submitted its voluntary Sustainability Report for FY 2025-26 to BSE/NSE, prepared with reference to GRI Standards.
The report highlights a 47% reduction in Scope 1 emissions, 16.6 MW ins
